Medicus Pharma Ltd.
MDCX.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 109.04% | 63.24% | 228.98% | 634.22% | 142.21% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 132.42% | 434.02% | 1,313.67% | 873.51% | 336.50% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 33.52% | -- | -93.13% | -- | -- |
| Total Current Assets | 83.90% | 79.72% | 29.73% | 677.36% | 184.10% |
|
|
|||||
| Total Current Assets | 83.90% | 79.72% | 29.73% | 677.36% | 184.10% |
| Net Property, Plant & Equipment | -36.45% | -29.53% | -27.47% | -25.88% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 78.18% | 74.41% | 35.91% | 474.29% | 198.29% |
|
|
|||||
| Total Accounts Payable | 167.42% | 7.86% | -9.44% | 65.52% | 509.39% |
| Total Accrued Expenses | 132.75% | -- | -- | -- | 123.64% |
| Short-term Debt | 7,343.93% | -- | -- | -- | -14.16% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 25.11% | 25.53% | 14.65% | 69.20% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 330.93% | 434.98% | 314.08% | 156.45% | 195.06% |
|
|
|||||
| Total Current Liabilities | 330.93% | 434.98% | 314.08% | 156.45% | 195.06% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 7,343.93% | -- | -- | -- | -14.16% |
| Capital Leases | -70.81% | -59.76% | -46.79% | -40.82% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 299.02% | 383.78% | 272.80% | 120.01% | 221.42% |
|
|
|||||
| Common Stock & APIC | 99.62% | 75.81% | 39.01% | 80.30% | 69.88% |
| Retained Earnings | -122.63% | -102.38% | -62.07% | -64.58% | -62.85% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -102.16% | -126.06% | -49.64% | 451.95% | 182.05% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -102.16% | -126.06% | -49.64% | 451.95% | 182.05% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -98.81% | -123.05% | -49.64% | 451.95% | 182.05% |
|
|
|||||